Fuji Pharma Co.,Ltd.JP:4554Balance sheet

Market cap
¥47.6B
P/E ratio
12.3x
2013/092014/092015/092016/092017/092018/092019/092020/092021/092022/092023/092024/092025/09
Cash and cash equivalents -8,1735,1586,8155,5036,2518,49412,04110,1993,5462,3244,5855,448
Marketable securities, current -506506----------
Total cash & short-term investments-8,6795,6646,8155,5036,2518,49412,04110,1993,5462,3244,5855,448
Accounts receivable, net-11,62312,33713,07215,14216,90312,94411,70011,866----
Inventories-3,3414,6334,6413,6673,1693,4373,8583,4793,7145,1385,3815,945
Total current assets-33,16830,71432,30933,20835,50733,91934,97534,83434,72739,11442,46841,219
Property, plant and equipment, net-10,46510,61811,01611,70311,70011,71812,76714,39218,76220,54720,91115,622
Marketable securities, non-current -9310812858607,3427,0007,7627,33910,5877,0925,094
Total non-current assets-15,85815,05915,83816,34217,61026,81726,98729,40440,81046,21847,53144,444
Total assets -49,02745,77348,14749,55153,11760,73761,96264,23975,53885,33290,00085,664
Accounts payable-6,6356,1026,2915,7216,7464,8133,6805,7136,2495,6724,1404,570
Short-term debt-1,183-----1,0007,0008,30011,30015,30015,300
Long-term debt, current -9219211,921653-2,8401,6401,8402,4404,6106,5001,281
Total current liabilities-12,71810,98912,73911,51311,54612,01211,00420,19223,97529,77135,79728,145
Long-term debt, non-current -3,4962,5752,6532,0002,0005,5307,5906,63311,1936,583837,202
Total non-current liabilities-7,7646,1906,1815,4366,2209,36010,99611,36515,75614,3838,63914,912
Total liabilities -20,48217,18018,92116,94917,76721,37322,00131,55739,73244,15544,43743,057
Common stock and paid-in capital -8,8228,8228,8228,8228,8229,6409,6408,2088,2088,2088,2058,415
Retained earnings-19,01220,66921,94424,54127,11929,24330,42424,62826,54629,08234,25635,171
Stockholders' equity24,06628,54428,59329,22632,60135,35039,36339,96132,68135,80641,17745,56346,908
Total debt-5,6003,4964,5742,6532,0008,37010,23015,47321,93322,49321,88323,783
Net debt--3,079-2,168-2,241-2,850-4,251-124-1,8115,27418,38720,16917,29818,335
D/E ratio (%)-19.612.215.78.15.721.325.647.361.354.64850.7
Working capital-----